NCT06906341 2025-10-22Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersCorcept TherapeuticsPhase 2 Recruiting270 enrolled
NCT02993731 2023-11-15CanStem111PSumitomo Pharma America, Inc.Phase 3 Completed1,134 enrolled 18 charts
NCT04299880 2023-11-08Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsSumitomo Pharma America, Inc.Phase 1 Completed7 enrolled